ESBERITOX

pharmaceutical preparations and dietary supplement, all having therapeutic effects in the field of acute and chronic respiratory tract infections, adjuvant therapy in addition to a treatment with antibiotics in severe bacterial infections, bacterial skin infections, herpes simplex labialis susceptibility to infections due to a temporarily lowered resistance, leucopenia following radio and cytostatic therapy, cold and cough indications